Northampton Electronic Collection of Theses and Research

Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial

Patel, P. M., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Pandha, H., Elsheik, S., Hadjimichael, E., Villasanti, N., Adams, S. E., Cunnell, M., Metheringham, R. L., Brentville, V. A., Machado, L., Daniels, I., Gijon, M., Hannaman, D. and Durrant, L. G. (2018) Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. OncoImmunology. 7(6) 2162-4011.

10131:21341
[thumbnail of Combined manuscript including figures]
Combined manuscript including figures
complete manuscript.pdf - Accepted Version
Restricted to Repository staff only
10131:30779
[thumbnail of Patel_etal_TFO_2018_Targeting_gp100_and_TRP_2_with_a_DNA_vaccine_Incorporating_T_cell_epitopes_with_a_human_IgG1_antibody_induces_potent_T_cell_responses_that_are_associated_with_favourable_clinical_outcome_in_a_phase_I_II_trial]
Patel_etal_TFO_2018_Targeting_gp100_and_TRP_2_with_a_DNA_vaccine_Incorporating_T_cell_epitopes_with_a_human_IgG1_antibody_induces_potent_T_cell_responses_that_are_associated_with_favourable_clinical_outcome_in_a_phase_I_II_trial
Patel_etal_TFO_2018_Targeting_gp100_and_TRP_2_with_a_DNA_vaccine_Incorporating_T_cell_epitopes_with_a_human_IgG1_antibody_induces_potent_T_cell_responses_that_are_associated_with_favourable_clinical_outcome_in_a_phase_I_II_trial.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Information
Edit Item